Risk of Myocardial Infarction
Research analysis lead by Kamal Patel
All content reviewed by Examine.com Team.
Published:
Last Updated:
All content reviewed by Examine.com Team.
Published:
Last Updated:
Summary of Risk of Myocardial Infarction
Primary Information, Benefits, Effects, and Important Facts
Scientific Information on Risk of Myocardial Infarction
Human Effect Matrix
The Human Effect Matrix looks at human studies (it excludes animal and in vitro studies) to tell you what supplements affect risk of myocardial infarction
| Grade | Level of Evidence [show legend] |
|---|---|
|
Robust research conducted with repeated double-blind clinical trials |
|
Multiple studies where at least two are double-blind and placebo controlled |
|
Single double-blind study or multiple cohort studies |
|
Uncontrolled or observational studies only |
|
Level of Evidence
?
The amount of high quality evidence. The mo
re evidence, the more we can trust the results.
|
Outcome |
Magnitude of effect
?
The direction and size of the supplement's impact on
each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
|
Consistency of research results
?
Scientific research does not always agree. HIGH or
VERY HIGH means that most of the scientific research agrees.
|
Notes |
|---|---|---|---|---|
|
|
Vitamin B3 (Niacin) |
Minor
|
Very High See all 3 studies |
Mixed evidence, but a possible decrease in the risk of myocardial infarction rates with niacin supplementation (overall mortality from cardiovascular diseases doesn\'t seem to be altered).
|
|
|
Ginkgo biloba | - | - See study |
The risk of myocardial infarction (as well as other heart conditions such as angina) does not appear to be significantly affected by ginkgo supplementation.
|
|
|
Vitamin E | - | - See study |
Vitamin E does not appear to reduce the incidence rates of myocardial infarctions despite a reduction in cardiovascular disease mortality.
|